Chromatin accessibility and gene expression profiling of primary and metastatic ER+ breast cancer [RNA-seq]
RNA-seq (gene expression) · human · 32 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Breast cancerThis series is part of our curated briefing on it.
- Samples
- 32 samples: 15 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE316391_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA999001. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 31 samples.
How we read this: 15 replicated groups read from 32 sample titles; they account for 31 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9451529 R18LIV_1 R18LIV
- GSM9451530 R18LIV_2 R18LIV
- GSM9451531 R18LUN_1 R18LUN
- GSM9451532 R18LUN_2 R18LUN
- GSM9451533 R23LIV_1 R23LIV
- GSM9451534 R23LIV_2 R23LIV
- GSM9451535 R23LUN_1 R23LUN
- GSM9451536 R23LUN_2 R23LUN
- GSM9451537 R33LIV_1 R33LIV
- GSM9451538 R33LIV_2 R33LIV
- GSM9451539 R33LUN_1 R33LUN
- GSM9451540 R33LUN_2 R33LUN
- GSM9451541 R36LIV_1 R36LIV
- GSM9451542 R36LIV_2 R36LIV
- GSM9451543 R36LUN_1 R36LUN
- GSM9451544 R36LUN_2 R36LUN
- GSM9451545 R39BR_1
- GSM9451546 R39LIV_1 R39LIV
- GSM9451547 R39LIV_2 R39LIV
- GSM9451548 R49BR_1 R49B
- GSM9451549 R49BR_2 R49B
- GSM9451550 R49BR_3 R49B
- GSM9451551 R49LIV_1 R49LIV
- GSM9451552 R49LIV_2 R49LIV
- GSM9451553 R49LUN_1 R49LUN
- GSM9451554 R49LUN_2 R49LUN
- GSM9451555 R8BR_1 R8B
- GSM9451556 R8BR_2 R8B
- GSM9451557 R8LIV_1 R8LIV
- GSM9451558 R8LIV_2 R8LIV
- GSM9451559 R8LUN_1 R8LUN
- GSM9451560 R8LUN_2 R8LUN
- GSE104193 Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signalling and malignant features in vitro and in vivo 32 samples same disease briefing · shares breast
- GSE104675 Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6 samples same disease briefing · shares breast
- GSE10886 A Supervised Risk Predictor of Breast Cancer Based on Biological Subtypes 226 samples same disease briefing · shares breast
- GSE11121 The humoral immune system has a key prognostic impact in node-negative breast cancer 200 samples same disease briefing · shares breast
- GSE10885 An integromic analysis reveals that metaplastic carcinomas are distinct from basal-like tumors. 244 samples same disease briefing
- GSE316389 Chromatin accessibility and gene expression profiling of primary and metastatic ER+ breast cancer [ATAC-seq] 36 samples shares accessibility, metastatic, chromatin, primary, breast
- GSE205154 Bulk RNA-Seq gene expression data for 289 primary and metastatic pancreatic ductal adenocarcinoma (PDAC) tumor samples from FFPE blocks. 289 samples shares metastatic, primary, rna-seq
- GSE306201 Single-cell RNA sequencing reveals different cellular states in malignant cells and the tumor microenvironment in primary and metastatic ER-positive breast cancer 22 samples shares metastatic, primary, breast
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.